Unraveling AMPK and BET regulation of immune checkpoint biology: implications for personalized medicine

Insights

Triple negative breast cancer (TNBC) patients with type 2 diabetes (T2D) have poorer outcomes. Bromodomain and ExtraTerminal domain (BET) proteins and 5' Adenosine Monophosphate-activated Protein Kinase (AMPK) influence immune checkpoints, potentially improving immunotherapy for TNBC with T2D.

Area of Science:

  • Immunology
  • Oncology
  • Metabolic Disease

Background:

  • Triple negative breast cancer (TNBC) patients with type 2 diabetes (T2D) exhibit worse survival rates.
  • The efficacy of immune checkpoint blockade (ICB) in TNBC is not well-defined.
  • Type 2 diabetes (T2D) is associated with immune suppression, and metformin's activation of 5' Adenosine Monophosphate-activated Protein Kinase (AMPK) warrants investigation into AMPK's role in immune checkpoint regulation.

Purpose of the Study:

  • To investigate the role of AMPK and Bromodomain and ExtraTerminal domain (BET) proteins in regulating immune checkpoint expression in TNBC.
  • To explore potential therapeutic strategies for improving ICB efficacy in TNBC patients, particularly those with comorbid T2D.

Main Methods:

  • Utilized flow cytometry to analyze immune checkpoint protein expression (TIM-3, TIGIT, PD-1, CTLA-4) on stimulated peripheral blood mononuclear cells.
  • Employed chemical inhibition of AMPK (Compound C) and BET proteins (pan-BET inhibitor JQ1, BRD4-selective PROTAC inhibitor MZ-1) to assess their regulatory pathways.

Main Results:

  • BET proteins differentially regulate immune checkpoint proteins TIM-3, TIGIT, PD-1, and CTLA-4.
  • BET proteins regulate PD-1 and CTLA-4 via an AMPK-dependent pathway.
  • BET proteins regulate TIM-3 and TIGIT via an AMPK-independent pathway.

Conclusions:

  • BET proteins and AMPK play distinct roles in regulating immune checkpoints relevant to TNBC.
  • Targeting BET proteins and AMPK pathways may offer personalized therapeutic strategies to enhance ICB efficacy in TNBC patients with T2D.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
The Spindle Assembly Checkpoint02:19

The Spindle Assembly Checkpoint

The spindle assembly checkpoint is a molecular surveillance mechanism ensuring the fidelity of chromosome segregation during anaphase. The checkpoint monitors the completion of all the prerequisite steps before chromosome segregation to determine whether the segregation process should proceed or be delayed.
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
3.9K
What is Conservation Biology?01:57

What is Conservation Biology?

Conservation biology is a scientific field that focuses on the preservation of biodiversity in order to protect ecosystems while meeting the needs of the human population. Humans require properly functioning ecosystems to maintain our supply of natural resources, including food, medicines, and building materials.
24.4K
What is the Immune System?01:38

What is the Immune System?

Overview
131.2K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.9K
GTPases and their Regulation02:14

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
9.9K